Showing results (181-190 of 288) with videos related to

Sort By:
Pageof 29
Advances in Therapy|March 26, 2021
Fixed Dose of Cemiplimab in Patients with Advanced Malignancies Based on Population Pharmacokinetic AnalysisAnne J Paccaly, Michael R Migden, Kyriakos P Papadopoulos, et al.
The Journal of Experimental Medicine|July 28, 2020
Profiling HPV-16-specific T cell responses reveals broad antigen reactivities in oropharyngeal cancer patientsKunal H Bhatt, Michelle A Neller, Sriganesh Srihari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2011
Prognostic significance of plasma osteopontin in patients with locoregionally advanced head and neck squamous cell carcinoma treated on TROG 02.02 phase III trialAnnette M Lim, Danny Rischin, Richard Fisher, et al.
Cancer Immunology Research|January 31, 2018
Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell CarcinomaBenjamin Solomon, Richard J Young, Mathias Bressel, et al.
Journal of Medical Imaging and Radiation Oncology|July 23, 2013
Imaging of hypoxia with 18F-FAZA PET in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapyMateya E Trinkaus, Rob Blum, Danny Rischin, et al.
Journal of Medical Imaging and Radiation Oncology|February 18, 2014
Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancerMateya E Trinkaus, Rodney J Hicks, Richard J Young, et al.
Pageof 29